153 related articles for article (PubMed ID: 26492094)
1. A systematic study comparing aspirate versus trephine for quantifying plasma cell infiltration in newly-diagnosed myeloma.
Gabriel J; McGovern A; Robinson S; Wright D; Chevassut T
Br J Haematol; 2016 Sep; 174(5):818-20. PubMed ID: 26492094
[No Abstract] [Full Text] [Related]
2. The sensitivity of CD138 immunostaining of bone marrow trephine specimens for quantifying marrow involvement in MGUS and myeloma, including samples with a low percentage of plasma cells.
Ng AP; Wei A; Bhurani D; Chapple P; Feleppa F; Juneja S
Haematologica; 2006 Jul; 91(7):972-5. PubMed ID: 16818287
[TBL] [Abstract][Full Text] [Related]
3. Prognostic impact of circulating plasma cells in patients with multiple myeloma: implications for plasma cell leukemia definition.
Granell M; Calvo X; Garcia-Guiñón A; Escoda L; Abella E; Martínez CM; Teixidó M; Gimenez MT; Senín A; Sanz P; Campoy D; Vicent A; Arenillas L; Rosiñol L; Sierra J; Bladé J; de Larrea CF;
Haematologica; 2017 Jun; 102(6):1099-1104. PubMed ID: 28255016
[TBL] [Abstract][Full Text] [Related]
4. Comparison of plasma cell infiltration in bone marrow biopsies and aspirates in patients with multiple myeloma.
Terpstra WE; Lokhorst HM; Blomjous F; Meuwissen OJ; Dekker AW
Br J Haematol; 1992 Sep; 82(1):46-9. PubMed ID: 1419801
[TBL] [Abstract][Full Text] [Related]
5. [80-year-old patient with dyspnoea, back ache and peripheral oedema. Plasma cell leukemia in multiple myeloma].
Austein T; Demme B
Dtsch Med Wochenschr; 2010 Nov; 135(44):2187-8. PubMed ID: 20979004
[No Abstract] [Full Text] [Related]
6. Discrepancies between the percentage of plasma cells in bone marrow aspiration and BM biopsy: Impact on the revised IMWG diagnostic criteria of multiple myeloma.
Lee N; Moon SY; Lee JH; Park HK; Kong SY; Bang SM; Lee JH; Yoon SS; Lee DS
Blood Cancer J; 2017 Feb; 7(2):e530. PubMed ID: 28211888
[No Abstract] [Full Text] [Related]
7. Bone marrow trephine combined with immunohistochemistry is superior to bone marrow aspirate in follow-up of myeloma patients.
Joshi R; Horncastle D; Elderfield K; Lampert I; Rahemtulla A; Naresh KN
J Clin Pathol; 2008 Feb; 61(2):213-6. PubMed ID: 17526802
[TBL] [Abstract][Full Text] [Related]
8. [IgG-lambda-type multiple myeloma with plasma-cell pericardial effusion and terminal plasma-cell leukemia].
Klug S; Höltermann F; Fritsch H
Dtsch Med Wochenschr; 1992 Jun; 117(23):900-4. PubMed ID: 1597118
[TBL] [Abstract][Full Text] [Related]
9. Aggressive and extramedullary plasma cell myeloma evade bone marrow flow cytometric minimal residual disease detection.
Came N; Nguyen V; Westerman D; Harrison S
Br J Haematol; 2016 Jun; 173(6):947-9. PubMed ID: 26456706
[No Abstract] [Full Text] [Related]
10. Primary plasma cell leukemia: consensus definition by the International Myeloma Working Group according to peripheral blood plasma cell percentage.
Fernández de Larrea C; Kyle R; Rosiñol L; Paiva B; Engelhardt M; Usmani S; Caers J; Gonsalves W; Schjesvold F; Merlini G; Lentzch S; Ocio E; Garderet L; Moreau P; Sonneveld P; Badros A; Gahrton G; Goldschmidt H; Tuchman S; Einsele H; Durie B; Wirk B; Musto P; Hayden P; Kaiser M; Miguel JS; Bladé J; Rajkumar SV; Mateos MV
Blood Cancer J; 2021 Dec; 11(12):192. PubMed ID: 34857730
[TBL] [Abstract][Full Text] [Related]
11. Catheter insertion site plasmacytoma.
Arango M; Echeverri C
Hematol Oncol Stem Cell Ther; 2016 Mar; 9(1):34-5. PubMed ID: 26276079
[No Abstract] [Full Text] [Related]
12. Polychromatic flow cytometry is more sensitive than microscopy in detecting small monoclonal plasma cell populations.
Tran DN; Smith SA; Brown DA; Parker AJ; Joseph JE; Armstrong N; Sewell WA
Cytometry B Clin Cytom; 2017 Mar; 92(2):136-144. PubMed ID: 27416483
[TBL] [Abstract][Full Text] [Related]
13. Quantification of bone marrow plasma cell infiltration in multiple myeloma: usefulness of bone marrow aspirate clot with CD138 immunohistochemistry.
Matsue K; Matsue Y; Kumata K; Usui Y; Suehara Y; Fukumoto K; Fujisawa M; Narita K; Takeuchi M
Hematol Oncol; 2017 Sep; 35(3):323-328. PubMed ID: 27140172
[TBL] [Abstract][Full Text] [Related]
14. Multiple myeloma: New surface antigens for the characterization of plasma cells in the era of novel agents.
Muccio VE; Saraci E; Gilestro M; Gattei V; Zucchetto A; Astolfi M; Ruggeri M; Marzanati E; Passera R; Palumbo A; Boccadoro M; Omedè P
Cytometry B Clin Cytom; 2016 Jan; 90(1):81-90. PubMed ID: 26287276
[TBL] [Abstract][Full Text] [Related]
15. Audit of bone marrow aspirates and trephine biopsies in multiple myeloma--a single centre study.
Charles KS; Winfield DA; Angel C; Goepel J
Clin Lab Haematol; 2004 Dec; 26(6):403-6. PubMed ID: 15595998
[TBL] [Abstract][Full Text] [Related]
16. [Plasma cell infiltration of the liver in multiple myeloma].
Sucker C; Dölken G; Preuss J; Schwesinger G; Stockschläder M
Dtsch Med Wochenschr; 2002 Jul; 127(27):1469-72. PubMed ID: 12098098
[No Abstract] [Full Text] [Related]
17. A case of aggressive multiple myeloma with convoluted and multilobated plasma cell nuclei and no visible nucleoli.
Islam A; Noyes S; Henderson ES
Br J Haematol; 1990 Oct; 76(2):306-7. PubMed ID: 2133377
[No Abstract] [Full Text] [Related]
18. Secondary plasma cell leukaemia (PCL) with plasmablastic morphology.
Xu K; Nacheva E
J Hematop; 2024 Jun; 17(2):117-119. PubMed ID: 38580782
[TBL] [Abstract][Full Text] [Related]
19. Diffuse plasma cell infiltration of liver detected initially at diagnosis of multiple myeloma.
Guney T; Bakanay Ozturk SM; Hacibekiroglu T; Akinci S; Basturk A; Dilek I
Clin Ter; 2013; 164(6):e509-10. PubMed ID: 24424232
[TBL] [Abstract][Full Text] [Related]
20. Signet-ring plasma cell myeloma.
Grier DD; Robbins K
Am J Hematol; 2012 Jun; 87(6):625. PubMed ID: 21953819
[No Abstract] [Full Text] [Related]
[Next] [New Search]